Department of Physical Therapy, University of Florida, Box 100154, UFHSC, Gainesville, Florida, 32610, USA.
The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Muscle Nerve. 2018 Nov;58(5):631-638. doi: 10.1002/mus.26161. Epub 2018 Jul 24.
Tests of ambulatory function are common clinical trial endpoints in Duchenne muscular dystrophy (DMD). Using these tests, the ImagingDMD study has generated a large data set that can describe the contemporary natural history of DMD in 5-12.9-year-olds.
Ninety-two corticosteroid-treated boys with DMD and 45 controls participated in this longitudinal study. Participants performed the 6-minute walk test (6MWT) and timed function tests (TFT: 10-m walk/run, climbing 4 stairs, supine to stand).
Boys with DMD had impaired functional performance even at 5-6.9 years old. Boys older than 7 had significant declines in function over 1 year for 10-m walk/run and 6MWT. Eighty percent of participants could perform all functional tests at 9 years old. TFTs appear to be slightly more responsive and predictive of disease progression than the 6MWT in 7-12.9 year olds.
This study provides insight into the contemporary natural history of key functional endpoints in DMD. Muscle Nerve 58: 631-638, 2018.
在杜氏肌营养不良症(DMD)中,运动功能测试是常见的临床试验终点。通过这些测试,ImagingDMD 研究产生了一个大型数据集,可描述 5-12.9 岁 DMD 患儿的当代自然病史。
92 名接受皮质类固醇治疗的 DMD 男孩和 45 名对照者参加了这项纵向研究。参与者进行了 6 分钟步行测试(6MWT)和计时功能测试(TFT:10 米步行/跑,爬 4 级楼梯,仰卧位站立)。
即使在 5-6.9 岁时,患有 DMD 的男孩的功能表现也受损。7 岁以上的男孩在 1 年内 10 米步行/跑和 6MWT 的功能显著下降。80%的参与者在 9 岁时可以进行所有功能测试。在 7-12.9 岁的儿童中,TFT 似乎比 6MWT 更敏感,更能预测疾病进展。
这项研究深入了解了 DMD 中关键功能终点的当代自然病史。肌肉神经 58:631-638,2018。